Vir Biotechnology’s Early Promise in Clinical Trials Warrants Hold Rating Amid Uncertainties
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...
Vir Biotechnology’s Early Stage Developments and Valuation Lead to Hold Rating Amid Long-Term Promise and Near-Term Uncertainties
Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...
Macrophages, not T cells, may hold key to predicting which melanoma patients are more likely to respond to immunotherapy
An international team of UK and US scientists has discovered that the activity of macrophages—a type of white blood cell that ...
M42's IROS And Halia Therapeutics Launch Clinical Study On Obesity Treatment In The UAE
Trial underscores IROS's commitment to developing innovative therapies for unmet medical needs <li /> The study's success ...
Cassava Sciences issues layoffs, regroups after failed drug study
An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...
AI is already changing the ways we fight cancer
A study published today in the journal Nature by researchers at Columbia University described a new medical AI model that ...
Building digital twins and hearts: New technology could predict various health outcomes
Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A ...
manilatimes23h
Artificial Intelligence in Clinical Trials Market to Hit US$ 2.74 Billion by 2030 with 12.4% CAGR | MarketsandMarkets™.
The global artificial intelligence in clinical trials market, valued at US$1.20 billion in 2023, is forecasted to grow at a ...
Arabian Business1d
Abu Dhabi’s IROS to collaborate in clinical study on obesity treatment
US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...
News Medical1d
Multidisciplinary Hispanic health study receives $21 million NIH grant
A multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community has received a $21 million grant from the ...
EurekAlert!1d
New AI platform identifies which patients are likely to benefit most from a clinical trial
A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial ...